ChartRow logo
Data provided bySource: Twelve Data
SOLV
$90.38+3.67%
as of close, Nov 6, 2026
☾ AH $90.38 +3.67%
PeersBAXCOOALGNDXCMFTVBR
Share this page

SOLV — Solventum Corporation price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in SOLV be worth today? →
SOLV returns: By year · By month · By week · Trailing

Price data

Price
$90.38
YTD price return
+14.06%
YTD total return
+14.06%
Market cap
15.3B
Enterprise value
20.4B
Shares outstanding
169.7M
52W low
$62.38
52W high
$94.16
From 52W high
-4.01%
From 52W low
+44.89%
52W range
88%$62.38–$94.16

Volume

Rel volume
2.69×
30D volume
1.2M
30D $ vol
101.8M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
none
Insider net 1Y
+$100K

Form 4 transactions by trade date, as filed; latest on file 2026-03-10.

Fundamentals

Sales (ttm)
8.2B
Sales/share
$48.09
EPS (ttm)
$0.90
FCF (ttm)
0
FCF/share
$0.00
Book value/share
$28.31
Net margin
1.91%
ROE
3.25%
ROA
1.10%
Debt / equity
0.95×
Current ratio
1.03

Growth (CAGR, ttm) · 10Y

Sales
-2.85%-0.15%n/an/a
Net income
-89.78%-54.34%n/an/a
Shares
-2.14%-0.57%n/an/a

Per-share growth (CAGR, ttm) · 10Y

EPS
-89.71%-54.45%n/an/a
Sales/share
-0.72%+0.48%n/an/a
Book value/share
-1.53%-24.98%n/an/a
Price
+36.39%+4.78%n/an/a
Total return
+36.39%+4.78%n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
100.7×
Fwd P/E
12.4×
P/S (ttm)
1.9×
P/B (mrq)
3.2×
EV/EBITDA (fy)
20.9×
EV/Sales (ttm)
2.5×
FCF yield (ttm)
0.00%
Buyback yield (realized, 1y)
2.14%
Shareholder yield (realized, 1y)
2.14%
Buyback yield (cash, ttm)
2.63%
Shareholder yield (cash, ttm)
2.63%

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+3.67%
5D
+11.13%
1M
+3.84%
3M
+8.94%
YTD
+14.06%
1Y
+36.36%
5Y
—
1D
+3.67%
5D
+11.13%
1M
+3.84%
3M
+8.94%
YTD
+14.06%
1Y
+36.36%
5Y
—

Fundamentals#

Revenue

YoY −7.0%
$8.2B TTM$1.9B Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

YoY −96.0%
$454M TTM$68M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

YoY n/m
$0.90 TTM−$0.07 Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

YoY n/m
$0 TTM$97M Q3 '26
FY22FY23FY24FY25TTM

TTM: operating cash flow $310M, capex −$310M

Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $177M, capex −$80M

Shares (diluted)

YoY −2.6%
173.9M TTM170.8M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

YoY n/m
$156M TTM−$12M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full SOLV financials →

Solventum Corporation is a healthcare company that develops and commercializes a broad portfolio of products and software designed to address clinical and operational needs across care settings. Its Medsurg business provides wound care, skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, and medical electrodes. The Dental Solutions segment offers products used in restorative and orthodontic workflows, including brackets, aligners, cements, and bonding agents. Through Health Information Systems, Solventum supplies software and services that support physician documentation, coding automation, speech recognition, and data visualization for healthcare organizations. The company serves customers in the United States and internationally through direct sales, distribution, key account management, inside sales, and e-commerce. Headquartered in Eagan, Minnesota, Solventum focuses on technologies that support safer, more efficient healthcare delivery.

Eagan, MN·20,584 employees·Medical Instruments & Supplies·solventum.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding SOLV#

27 of the 193 ETFs ChartRow carries live hold SOLV. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VBRVanguard Small-Cap Value ETF0.2%
RSPInvesco S&P 500 Equal Weight ETF0.2%
XLVHealth Care Select Sector SPDR Fund0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
SPYVSPDR Portfolio S&P 500 Value ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%